Skip to main content

Association of CD49d and CD44 in chronic lymphocytic leukemia patients and their effects on response to fludarabine, cyclophosphamide, and rituximab therapy

Research Authors
Maged S Mahmoud, Eman M Salaheldin, Noha G Sayed, Alshymaa F Solyman
Research Date
Research Journal
Journal of Current Medical Research and Practice
Research Publisher
Medknow
Research Vol
vol 3 , issue 3
Research Website
https://scholar.google.com.eg/scholar?oi=bibs&cluster=3614025336075884469&btnI=1&hl=en
Research Year
2018
Research_Pages
147-153
Research Abstract

Chronic lymph ocytic leukemia (CLL) is a clonal expansion of small mature lymphocytes accumulating in the blood, bone marrow, and lymphoid organs. The interactions of the CLL microenvironment are known to promote CLL cell survival and proliferation. CD49d, an adhesion molecule belonging to the integrin family mediates cell-to-extracellular matrix and cell-to-cell interactions. CD44 is a glycoprotein and also a major hyaluronan receptor that mediates the response of cells to their cellular microenvironment.